Neurofibroma classification: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:


==Classification==
==Classification==
[[Neurofibroma]] may be [[Classification|classified]] into following 5 subtypes:<ref name="libre">Neurofibroma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Neurofibroma#cite_note-pmid15486243-2 Accessed on November 17, 2015 </ref><ref>http://www.nfmidwest.org/wp-content/uploads/2016/03/Neurofibromas.pdf</ref><ref>https://pubs.rsna.org/doi/10.1148/rg.24si035170#REF8</ref>
[[Neurofibroma]] may be [[Classification|classified]] into following subtypes:<ref name="libre">Neurofibroma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Neurofibroma#cite_note-pmid15486243-2 Accessed on November 17, 2015 </ref><ref>http://www.nfmidwest.org/wp-content/uploads/2016/03/Neurofibromas.pdf</ref><ref>https://pubs.rsna.org/doi/10.1148/rg.24si035170#REF8</ref><ref>http://surgpathcriteria.stanford.edu/peripheral-nerve/neurofibroma/</ref>
{| class="wikitable"
{| class="wikitable"
|+
|+
Line 33: Line 33:
* Malignant transformation very rare
* Malignant transformation very rare
|-
|-
|'''Localized Intraneural neurofibroma'''
|style="background:#DCDCDC;" align="center" + |'''Localized Intraneural neurofibroma'''
|
|
* Second-most common type
* Second-most common type

Revision as of 17:24, 29 March 2019

Neurofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibroma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibroma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibroma classification

CDC on Neurofibroma classification

Neurofibroma classification in the news

Blogs on Neurofibroma classification

Directions to Hospitals Treating Neurofibroma

Risk calculators and risk factors for Neurofibroma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Neurofibroma may be classified into 5 subtypes: cutaneous/dermal/localized, subcutaneous, diffuse, intramuscular, and plexiform neurofibroma. Plexiform neurofibromas may be further sub-classified into diffuse and nodular plexiform.

Classification

Neurofibroma may be classified into following subtypes:[1][2][3][4]

Types of neurofibromas Characteristics/Description
Cutaneous/Dermal/Localized/Sporadic neurofibroma (90%)
  • Most common type
  • Circumscribed but not encapsulated
  • Permeative growth in nerve quickly proceeds to diffuse infiltration of surrounding soft tissue
  • Occurs as lumps or bumps on skin
  • Painless
  • Slowly growing
  • Often in dermis and subcutis
  • ≤2-5 cm in diameter
  • Arise from small cutaneous nerves
  • Overrun axons may be identified within
  • May contain fat
  • < 5cm diameter
  • Starts in teenage years or young adults and rarely starts in childhood
  • Increases in size and number over the years
  • Clearly defined borders hence, can be removed if necessary
  • Number of skin tumors in each patient varies tremendously
  • Mostly solitary and sporadic, not associated with NF1
  • Malignant transformation very rare
Localized Intraneural neurofibroma
  • Second-most common type
  • Segmental, fusiform nerve enlargement
  • Residual axons traverse through lesion
    • Neurofilament immunohistochemistry and Bielshowsky stain show axons within center of lesion
  • Often contains coarse, refractile collagen
  • Malignant change infrequent
Subcutaneous neurofibroma
Diffuse neurofibroma

(superficial)

  • Superficial
  • Uncommon
  • Feels soft and squishy
  • Most common in head (scalp) and neck region or trunk (often protruding out, like a “love handle”)
  • Ill defined margins, can't tell where tumor stops
  • Runs through the full skin thickness (from the surface all the way down to the base of the skin (subcutaneous fascia/fat)
  • Doesn't go deeper than fascia
  • Nondestructive, envelops normal structures (e.g., fat cells and adnexal structures)
  • Uniform matrix of fine, fibrillary collagen
  • Shorter, rounder Schwann cells
  • Clusters of pseudomeissnerian body-like structures may be seen
  • Usually seen in early childhood and young adults
  • Usually associated with diffuse hyperpigmentation, so looks like a very large squishy café au lait spot
  • Solitary lesions and not related to any inherited condition (rarely associated with NF1)
  • Rare malignant change
Intramuscular neurofibroma
  • Common
  • Usually isolated tumors in the muscle
  • Growths along very small nerves
  • Causes pain sometimes
  • Can be removed (leaves a scar behind)
  • Sometimes can occur as plexiform neurofibromas in form of chains or networks
Plexiform neurofibroma

(deep)

  • Deep
  • Associated with NF1
  • Diffuse involvement along a large nerve and its branches
  • Mostly internal/ intraneural
  • Can also involve small nerves and superficial skin
  • Have more connective tissue/extracellular matrix than cutaneous neurofibromas, that separates the nerve fibers
  • Gross enlargement of the nerve with nodular tumor development results in the gross pathologic appearance referred to as “bag of worms”
  • Generally believed to be present at birth (congenital)
  • Disfiguring
  • Affects function due to sheer size as well as neurovascular compromise
  • Upto 5% risk of malignant transformation
  • Plexiform neurofibroma exhibits following features on T2-weighted MRI:
    • Target sign (low signal intensity centrally with a ring of high signal intensity peripherally)
    • Fascicular sign
    • May appear as a larger and more infiltrating mass with lobulated borders with inhomogeneous enhancement
Pigmented neurofibroma
  • Neurofibroma with melanin-bearing pigmented cells, usually only appreciated microscopically
  • Not considered a true subtype
  • No increased risk of malignant transformation

Plexiform neurofibromas can be further subclassified into following:[5]

Types of neurofibromas Characteristics/Description
Diffuse Plexiform neurofibroma
Nodular Plexiform neurofibroma

References


Template:WikiDoc Sources